Salesforce
CRM
Adobe
ADBE
Oracle
ORCL
Amazon
AMZN
Broadcom
AVGO
US Stock MarketDetailed Quotes
ADVM Adverum Biotechnologies
- 6.3200
- -0.0100-0.16%
Trading Dec 4 10:01 ET
131.47MMarket Cap-1062P/E (TTM)
6.4400High6.3200Low8.51KVolume6.3400Open6.3300Pre Close54.27KTurnover0.07%Turnover RatioLossP/E (Static)20.80MShares29.700052wk High0.91P/B79.57MFloat Cap5.690052wk Low--Dividend TTM12.59MShs Float624.8000Historical High--Div YieldTTM1.90%Amplitude5.3100Historical Low6.3740Avg Price1Lot Size
Adverum Biotechnologies Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1M | 0 | 0 | 3.6M | 0 | 0 | 0 | 3.6M | 0 | 0 |
| Operating revenue | --1M | --0 | --0 | --3.6M | --0 | --0 | --0 | --3.6M | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -12.48%30.22M | -36.85%20.88M | -20.69%26.84M | -18.80%127.59M | -22.93%26.16M | -15.86%34.53M | -24.89%33.07M | -11.26%33.84M | 2.29%157.14M | -1.39%33.94M |
| Selling and administrative expenses | -29.06%9.78M | -69.64%3.79M | -10.57%11.43M | -13.73%49.92M | -7.33%10.88M | -19.78%13.79M | -9.40%12.47M | -15.75%12.78M | -10.22%57.86M | -1.29%11.74M |
| -General and administrative expense | -29.06%9.78M | -69.64%3.79M | -10.57%11.43M | -13.73%49.92M | -7.33%10.88M | -19.78%13.79M | -9.40%12.47M | -15.75%12.78M | -10.22%57.86M | -1.29%11.74M |
| Research and development costs | -1.45%20.44M | -17.00%17.1M | -26.82%15.41M | -21.76%77.68M | -31.18%15.28M | -13.04%20.74M | -31.94%20.6M | -8.30%21.06M | 11.32%99.28M | -1.44%22.2M |
| Operating profit | 15.37%-29.22M | 36.85%-20.88M | 11.24%-26.84M | 21.09%-123.99M | 22.93%-26.16M | 15.86%-34.53M | 24.89%-33.07M | 20.70%-30.24M | -7.54%-157.14M | 1.39%-33.94M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 25.65%2.09M | 52.66%2.41M | 71.00%2.05M | 115.04%5.75M | 7.20%1.31M | 79.96%1.66M | 456.89%1.58M | 391.80%1.2M | 359.28%2.67M | 12,130.00%1.22M |
| Other non- operating income (expenses) | 25.65%2.09M | 52.66%2.41M | 71.00%2.05M | 115.04%5.75M | 7.20%1.31M | 79.96%1.66M | 456.89%1.58M | 391.80%1.2M | 359.28%2.67M | 12,130.00%1.22M |
| Income before tax | 17.45%-27.13M | 41.33%-18.48M | 14.64%-24.79M | 23.45%-118.24M | 24.05%-24.85M | 18.06%-32.87M | 28.01%-31.49M | 23.36%-29.04M | -6.13%-154.46M | 4.92%-32.72M |
| Income tax | 0 | 0 | 0 | -1,556.76%-1.08M | -6,063.16%-1.13M | 0.00%17K | 10.53%21K | -10.53%17K | 74K | 19K |
| Net income | 17.49%-27.13M | 41.36%-18.48M | 14.69%-24.79M | 24.18%-117.17M | 27.56%-23.71M | 18.06%-32.89M | 28.00%-31.51M | 23.35%-29.06M | -6.18%-154.54M | 4.86%-32.74M |
| Net income continuous Operations | 17.49%-27.13M | 41.36%-18.48M | 14.69%-24.79M | 24.18%-117.17M | 27.56%-23.71M | 18.06%-32.89M | 28.00%-31.51M | 23.35%-29.06M | -6.18%-154.54M | 4.86%-32.74M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 17.49%-27.13M | 41.36%-18.48M | 14.69%-24.79M | 24.18%-117.17M | 27.56%-23.71M | 18.06%-32.89M | 28.00%-31.51M | 23.35%-29.06M | -6.18%-154.54M | 4.86%-32.74M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 17.49%-27.13M | 41.36%-18.48M | 14.69%-24.79M | 24.18%-117.17M | 27.56%-23.71M | 18.06%-32.89M | 28.00%-31.51M | 23.35%-29.06M | -6.18%-154.54M | 4.86%-32.74M |
| Basic earnings per share | 60.12%-1.3 | 71.57%-0.89 | 48.28%-1.5 | 25.64%-11.6 | 29.70%-2.32 | 18.50%-3.26 | 28.86%-3.13 | 23.68%-2.9 | -5.41%-15.6 | 5.71%-3.3 |
| Diluted earnings per share | 60.12%-1.3 | 71.57%-0.89 | 48.28%-1.5 | 25.64%-11.6 | 29.70%-2.32 | 18.50%-3.26 | 28.86%-3.13 | 23.68%-2.9 | -5.41%-15.6 | 5.71%-3.3 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |